ANDREW ELBARDISSI

Andrew ElBardissi stands as a pivotal Partner at Deerfield Management, a leading investment firm exclusively dedicated to advancing healthcare. Since joining Deerfield in 2013, Mr. ElBardissi has been instrumental in shaping the firm's private equity and venture capital initiatives, identifying and nurturing companies poised to revolutionize patient care and medical science. His work at Deerfield Management encompasses a broad spectrum of the healthcare landscape, with a particular focus on groundbreaking innovations in biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions. He is deeply committed to backing enterprises that offer novel therapies, improve healthcare delivery, and address unmet medical needs globally.

Mr. ElBardissi's investment philosophy is uniquely informed by his comprehensive background, which bridges clinical medicine, strategic consulting, and finance. He earned his Doctor of Medicine (MD) from Weill Cornell Medical College and an MBA from Columbia Business School, providing him with a rare dual perspective on both the scientific rigor and business acumen required for success in the healthcare industry. Prior to his tenure at Deerfield, Andrew ElBardissi honed his strategic insights as a consultant in the healthcare practice at McKinsey & Company, where he advised pharmaceutical, biotech, and medical device companies on critical strategic and operational challenges. He also completed a residency in internal medicine at NewYork-Presbyterian Hospital, giving him firsthand experience with the complexities of patient care and the practical applications of medical innovation.

This rich tapestry of experience allows Andrew ElBardissi to evaluate investment opportunities with a nuanced understanding of scientific validity, market potential, and clinical impact. He is adept at identifying early-stage companies with disruptive technologies as well as established firms seeking growth capital to expand their reach. While specific individual investments are often proprietary, his involvement at Deerfield Management means he contributes to a portfolio that includes many of the most promising ventures in life sciences. His leadership helps Deerfield Management continue its mission of investing in companies that are developing solutions to improve health outcomes and reduce the burden of disease. Andrew ElBardissi's strategic vision and profound industry knowledge make him a key figure in the healthcare investment community, driving innovation and fostering the growth of companies that are shaping the future of medicine.